EVER2 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76368
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Antibody was raised against a 18 amino acid synthetic peptide from near the amino terminus of human EVER2. The immunogen is located within amino acids 50 - 100 of EVER2. Amino Acid Squence: WRQWQRRRQTVERRLREA
Specificity
At least two isoforms of EVER2 are known to exist; this antibody will only recognize the larger isoform. EVER2 has no cross-reactivity to EVER1.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for EVER2 Antibody - BSA Free
Western Blot: EVER2 AntibodyBSA Free [NBP1-76368]
Western Blot: EVER2 Antibody [NBP1-76368] - Rat thymus tissue lysate with EVER2 antibody at (A) 1 and (B) 2 ug/ml.Applications for EVER2 Antibody - BSA Free
Application
Recommended Usage
ELISA
1:100-1:2000
Western Blot
1-2 ug/ml
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: EVER2
Alternate Names
epidermodysplasia verruciformis 2, Epidermodysplasia verruciformis protein 2, EV2, EVER2MGC102701, EVIN2FLJ43684, FLJ40668, MGC40121, transmembrane channel-like 8, transmembrane channel-like protein 8
Gene Symbol
TMC8
UniProt
Additional EVER2 Products
Product Documents for EVER2 Antibody - BSA Free
Product Specific Notices for EVER2 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...